However, as EMT has been associated with inflammatory tumor microenvironment and elevation of multiple targetable immune checkpoint molecules in lung cancer26, exploring the relation between CD56+ CTC and EMT in the context of the new immunotherapeutic strategies in SCLC would be an important avenue to explore. This evidence concerns the gene NCAM1 and neoplasm.